Sofiderm Derm Sub-Skin: best injectable body filler, AMWC 2026

On 26 March 2026, at the Aesthetic and Anti-Aging Medicine World Congress (AMWC) in Monaco, Sofiderm Derm Sub-Skin 20 ml won the Best Injectable Body Filler award. Over 1,000 entries came in from across the industry and 26 awards were given, judged by an independent panel on innovation, clinical efficacy, patient safety and market need. The result is on the official AMWC Awards winners list.

About the AMWC

The AMWC takes place every year in Monaco and is the world's largest aesthetic medicine congress: over 12,000 delegates from more than 100 countries. The AMWC Awards are the congress's awards programme. In 2026 they honoured 26 products, chosen from over 1,000 entries.

What the award recognised

Derm Sub-Skin is the most cohesive line in the Sofiderm range, made for the deep subcutaneous plane. Techderm's MCLPE cross-linking produces a cohesive, viscous hyaluronic acid gel at 20 ± 3 mg/ml, built for structural support at depth, class III CE-marked (notified body 2460, DNV) and manufactured under ISO 13485. Indications are those of the CE certificate; sizes run from 1 to 20 ml, and the 20 ml presentation is the one the panel awarded.

What changes for the clinic

Nothing in the chemistry, everything in the confidence: the product is the same, now with independent industry recognition behind it. An award is not a clinical indication. It is something to cite, when choosing a supplier, and the source is public.

Derm Sub-Skin 20 ml is available in Portugal and Spain through Orvida, the exclusive distributor in Portugal. For professional pricing, register your clinic or write to info@orvida.eu.

This article is informative and intended for healthcare professionals. It does not replace the instructions for use or clinical judgement. Sources: Regulation (EU) 2017/745, articles 14 and 25; manufacturer documentation; Orvida internal procedures.